Aspirin and hemocompatibility events with a left ventricular assist device in advanced heart failure

JAMA

2023-11-11

(Press-News.org) About The Study: This randomized clinical trial found that in patients with advanced heart failure treated with a fully magnetically levitated left ventricular assist device, avoidance of aspirin as part of an antithrombotic regimen, which includes a vitamin K antagonist, is not inferior to a regimen containing aspirin, does not increase thromboembolism risk, and is associated with a reduction in bleeding events.

Authors: Mandeep R. Mehra, M.D., M.Sc., of Brigham and Women’s Hospital and Harvard Medical School in Boston, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2023.23204)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Media advisory: This study is being released to coincide with presentation at the American Heart Association’s Scientific Sessions 2023.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.23204?guestAccessKey=36be1cb8-a086-4f1e-ac7e-1ff334f94ccc&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111123

END

ELSE PRESS RELEASES FROM THIS DATE:

New AHA Center for Telehealth™ will increase access to quality health care and improve delivery

2023-11-11

According to the American Medical Association, approximately 25% of all patients used telehealth services during the last year, exceeding the 5% who accessed their care this way before the pandemic.[1] The American Heart Association (AHA) Center for Telehealth, unveiled today, recognizes the critical role telehealth can play as a solution to close gaps in health care access, particularly in rural and underserved areas, and deliver quality care to populations that have little to no access to traditional ...

New study finds coronary calcium scores highly effective in identifying heart disease in people without any known risk factors

2023-11-11

While high cholesterol, high blood pressure, diabetes and smoking are well known heart disease risks, not everyone who has a heart attack has them. In fact, previous research has shown that 14% to 27% of heart attack patients have none of these risk factors. Now, a new study from researchers at Intermountain Health in Salt Lake City finds that these patients had one thing in common: they all tended to have high levels of coronary calcium. Results of the new Intermountain study show that scans that detect this kind of plaque buildup should be considered as ...

Understanding the stressed, depressed, adolescent brain

2023-11-11

WASHINGTON — Advanced brain imaging techniques reveal how adolescent brain development influences, and is influenced by, factors including chronic stress and mood disorders. The findings will be presented on Monday, November 13, 11:15 a.m. – 12:15 p.m. EST at Neuroscience 2023, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health. Adolescence is a time of social, biological, and emotional changes, as well as continued brain development. Mental health among teenagers was already declining before the COVID-19 pandemic, according to data from the Centers for Disease Control ...

The brain’s response to a changing environment

2023-11-11

WASHINGTON — Changes in a person’s environment can have long-term, significant effects on the brain, whether it’s the inhalation of wildfire smoke or the experience of childhood trauma. The findings will be presented on Tuesday, November 14, 11:15 a.m. – 12:15 p.m. at Neuroscience 2023, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health. The environment plays an important role in a person’s brain health and cognitive function. Previous research has established that both one’s physical and social environment effect the brain and nervous system. Next, researchers ...

The AI edge: How new tools are advancing neuroscience

2023-11-11

WASHINGTON — Using machine learning, researchers are able to use data from the brain to glean deeper insights and apply this new knowledge in clinical settings. The findings will be presented on Monday, November 13, 2–3 p.m. EST at Neuroscience 2023, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health. Machine learning is a branch of artificial intelligence (AI) that centers on enabling computers to analyze data in increasingly complex ...

Advances in predicting Alzheimer’s disease

2023-11-11

WASHINGTON — Researchers are making strides toward understanding and detecting Alzheimer’s disease in its earliest stages, when interventions may be most effective at slowing the progress of the disease. The findings will be presented on Sunday, November 12, 11:30 a.m. – 12:30 p.m. EST at Neuroscience 2023, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health. Alzheimer’s disease (AD) is a neurodegenerative ...

The biological blueprint for depression and its cognitive effects

2023-11-11

WASHINGTON — In studies that examine the depressed brain, researchers were able to identify specific genes, molecules, brain regions, and cognitive features that are associated with the disorder. The findings will be presented on Monday, November 13, 10–11 a.m. EST at Neuroscience 2023, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health. More than 8% of adults in the United States suffer from severe depression, and the percentage is higher ...

Unraveling anxiety: The roles of virtual reality, companionship, and infantile amnesia

2023-11-11

WASHINGTON — Innovative experimental approaches with human participants and animal models point to the effects of fear and stress on the brain — and suggest ways to ameliorate these impacts. The findings will be presented on Monday, November 13, 12:45–1:45 p.m. at Neuroscience 2023, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health. Fear and anxiety are normal, healthy emotional responses to some stimuli; however, there ...

Exploring psychedelics: Understanding variability in treatment responses

2023-11-11

WASHINGTON — Psychedelic compounds such as psilocybin, a substance found in various mushroom species, are garnering more research support as novel treatments for psychiatric disorders, but questions remain concerning who they may help the most. The findings will be presented on Tuesday, November 14, 1–2 p.m. at Neuroscience 2023, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health. Psychiatric disorders, including phobias, post-traumatic stress disorder (PTSD), depression, and substance use disorder, represent a major public health issue. Current behavioral and pharmacological ...

Scientific strength through diverse datasets

2023-11-11

Research which considers the diversity of normal and diseased human populations is contributing to more resilient hypotheses regarding complex neuroscience processes, such as human brain development, autism spectrum disorders, and Alzheimer's disease. Several interwoven examples will be discussed on Sunday, November 12, 2–3 p.m. at Neuroscience 2023, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health. Considering the full spectrum of human variability — including gender, sex, race, ethnicity, and neurodiversity — is benefiting neuroscience at both the basic and translational ...

Inhibition of cyclooxygenase-2 upregulates the nuclear factor erythroid 2-related factor 2 signaling pathway to mitigate hepatocyte ferroptosis in chronic liver injury

Aspirin and hemocompatibility events with a left ventricular assist device in advanced heart failure

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: